Managing Partners
PACE is a collaboration between three leaders in the UK’s health innovation and research community. It harnesses their unique expertise – catalysing and working with the global AMR community to accelerate the speed of innovation to mitigate the risk of AMR.
Partner Organisations
Innovate UK, LifeArc, and Medicines Discovery Catapult believe that the best approach to addressing AMR and protecting the lives of people around the world is to grow a pipeline of high-quality antimicrobial drugs and associated diagnostics. So, we came together to set up PACE to combine our expertise and resources, knowing that we can make a bigger impact together than we could alone.
LifeArc
LifeArc is a self-funded, not-for-profit medical research organisation, focused on translational science. They carry out their own research and provide funding and expert advice to others, all with the aim of improving patient lives.
One area of focus is global health, where they collaborate to accelerate innovation in infectious diseases. This includes the translational challenge in AMR, which aims to drive the better use of existing treatments and the development of new targeted therapies and diagnostics for AMR. PACE will be a vital part of this work.
LifeArc is registered charity in England and Wales under no. 1015243 and in Scotland under no. SC037861.
Innovate UK
Innovate UK, part of UK Research and Innovation (UKRI), is the UK’s innovation agency. It works to create a better future by inspiring, involving and investing in businesses developing life-changing innovations.
Its mission is to help companies to grow through their development and commercialisation of new products, processes and services, supported by an outstanding innovation ecosystem that is agile, inclusive and easy to navigate.
Innovate UK will play a leading role in building an innovation ecosystem around AMR that accelerates new discoveries and promotes economic growth for UK businesses.
Medicines Discovery Catapult (MDC)
Medicines Discovery Catapult reshapes drug discovery for patient benefit by transforming great UK science into better treatments through partnership. Through PACE, we will bring the AMR community together, and make it easier for innovators to turn their ideas into novel therapeutics and diagnostics. We offer our world-class capabilities so, together, we can accelerate the pace of antimicrobial innovation and save lives.
